Plasma Proteomics
10 x deeper 10 x faster
Nanomics Autolab
Large-Scale Proteomics Made Easy

Autolab offers seamless, high-throughput proteomics service for large-cohort studies.
We make it easy to get accurate, consistent data on a large scale, supporting everything from biomarker discovery to disease research.
Our automated platform is designed to handle big studies efficiently, so you get reliable insights faster.
How we ensure data quality?
Proteonano™
quality control system
In large cohort proteomics experiments with mass spec, subgroups of protein measurements with quantitatively different behaviors (i.e. batch effect) oftentimes hinders the downstream bioinformatic analysis.
Nanomics’ s Proteonano™ Ultraplex proteomics platform features a built-in quality control system (QCS), enabling comprehensive monitoring at the individual sample level.
Here’s how it works:

Stability of protein identification and inter-batch correlation for QC samples
We assessed the stability of protein enrichment using QC1 samples across 6 batches (a total of 18 QC1 samples). As shown in Figure 6, the median CV for protein quantity between batches is below 10%, and the median CV for protein intensity quantification is below 15%. This demonstrates the stability of protein enrichment across different batches in the project.

Figure 6: PGs identified for QC1 samples across 6 batches
We also assessed the pairwise correlations of the 18 QC1 samples throughout the project to ensure that Pearson correlation coefficients exceed 90% both between and within batches.

Figure 7: Pearson correlation across 18 QC1 samples from 6 batches
We will empower you to
discover protein biomarkers
and drive them through every step
to real-world applications
Step 3:
Translation
Step 2:
Validation

Step 1:
Discover
clinically validated biomarkers






“At Nanomics Autolab Center of Excellences, we are dedicated to providing the best services to accelerate mass spec-based large cohort clinical proteomics studies with excellent robustness, high-throughput, and cost-effectiveness.“
- Dr. Hao Wu, Founder & CEO of Nanomics

Ready to analyze? Get started here
Let’s talk about your project and see how our lab can help drive your research and support your diagnostic goals.
